Securities Class Action Against MannKind Dismissed
August 25 2016 - 9:00AM
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD)
announced that the United States District Court for the Central
District of California has dismissed the class action that was
pending against MannKind Corporation and two of its
executives. The Court granted the defendants’ motion to
dismiss the plaintiffs’ amended class action complaint without
leave to amend, thereby closing the case. The plaintiffs can
appeal the decision within 30 days.
ABOUT MANNKIND
CORPORATIONMannKind Corporation (Nasdaq:MNKD) (TASE:MNKD)
focuses on the discovery and development of therapeutic products
for patients with diseases such as diabetes. MannKind
maintains a website at www.mannkindcorp.com to which
MannKind regularly posts copies of its press releases as well as
additional information about MannKind. Interested persons can
subscribe on the MannKind website to e-mail alerts that are sent
automatically when MannKind issues press releases, files its
reports with the Securities and Exchange Commission or posts
certain other information to the website.
Company Contact:
Rose Alinaya
SVP, Finance
661-775-5300
ralinaya@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Aug 2024 to Sep 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Sep 2023 to Sep 2024